Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema

NCT00768040 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped Inadequate enrollment

Conditions

Diabetic Macular Edema

Interventions

DRUG: Aliskiren
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals